Dec 21 (Reuters) - Abcellera Biologics Inc ABCL.O :
* ABCELLERA BIOLOGICS INC - BAMLANIVIMAB (LY-COV555) WILL BE EVALUATED IN A NEW PRAGMATIC STUDY IN HIGH-RISK PATIENTS WITH COVID-19
Dec 21 (Reuters) - Abcellera Biologics Inc ABCL.O :
* ABCELLERA BIOLOGICS INC - BAMLANIVIMAB (LY-COV555) WILL BE EVALUATED IN A NEW PRAGMATIC STUDY IN HIGH-RISK PATIENTS WITH COVID-19